MIRUM PHARMACEUTICALS INC's ticker is MIRM and the CUSIP is 604749101. A total of 69 filers reported holding MIRUM PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $863,091 | +9.0% | 27,313 | -10.7% | 0.00% | 0.0% |
Q2 2023 | $791,648 | +33.7% | 30,601 | +24.1% | 0.00% | 0.0% |
Q1 2023 | $592,261 | +23.2% | 24,657 | +0.0% | 0.00% | 0.0% |
Q4 2022 | $480,714 | -5.7% | 24,652 | +1.5% | 0.00% | 0.0% |
Q3 2022 | $510,000 | +29.1% | 24,282 | +19.6% | 0.00% | 0.0% |
Q2 2022 | $395,000 | +1097.0% | 20,296 | +1244.1% | 0.00% | – |
Q1 2022 | $33,000 | +6.5% | 1,510 | -22.1% | 0.00% | – |
Q4 2021 | $31,000 | -18.4% | 1,939 | +2.1% | 0.00% | – |
Q3 2021 | $38,000 | -56.3% | 1,900 | -62.2% | 0.00% | – |
Q2 2021 | $87,000 | -49.4% | 5,025 | -42.2% | 0.00% | – |
Q1 2021 | $172,000 | +24.6% | 8,696 | +9.9% | 0.00% | – |
Q4 2020 | $138,000 | -9.8% | 7,916 | 0.0% | 0.00% | – |
Q3 2020 | $153,000 | -0.6% | 7,916 | 0.0% | 0.00% | – |
Q2 2020 | $154,000 | +38.7% | 7,916 | 0.0% | 0.00% | – |
Q1 2020 | $111,000 | +11.0% | 7,916 | +93.7% | 0.00% | – |
Q4 2019 | $100,000 | +138.1% | 4,086 | -2.5% | 0.00% | – |
Q3 2019 | $42,000 | – | 4,191 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RiverVest Venture Management LLC | 1,921,118 | $38,269,000 | 6.42% |
FRAZIER MANAGEMENT LLC | 3,566,912 | $71,053,000 | 5.68% |
Novo Holdings A/S | 2,445,147 | $48,707,000 | 2.52% |
Sio Capital Management, LLC | 248,978 | $4,960,000 | 1.58% |
Mesirow Financial Investment Management, Inc. | 25,795 | $514,000 | 1.51% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 3,282,912 | $65,396,000 | 1.28% |
NEA Management Company, LLC | 4,187,801 | $83,421,000 | 0.99% |
MPM BioImpact LLC | 308,532 | $6,146,000 | 0.95% |
Rock Springs Capital Management LP | 1,525,623 | $30,390,000 | 0.64% |
BVF INC/IL | 435,936 | $8,684,000 | 0.34% |